HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis.

Abstract
The Taenia crassiceps recombinant antigen KETc7 has been shown to be effective as a vaccine against experimental murine cysticercosis, a laboratory model used to test potentially promising molecules against porcine Taenia solium cysticercosis. Based on the deduced amino acid sequence of this proline-rich polypeptide, three fragments, GK-1, GK-2, and GK-3, were chemically synthesized in linear form. Of the three peptides, only GK-1 induced sterile protection against T. crassiceps cysticercosis in 40 to 70% of BALB/cAnN male mice. GK-1 is an 18-amino-acid peptide which contains at least one B-cell epitope, as demonstrated by its ability to induce an antibody response to the peptide and T. crassiceps antigen without need of a carrier protein. Immunofluorescence studies revealed that anti-GK1 antibodies strongly react with the native protein in the tegument of T. crassiceps and also with anatomical structures of T. solium eggs, oncospheres, cysticercus, and tapeworm. GK-1 also contains at least one T-cell epitope, capable of stimulating the proliferation of CD8(+) and to a lower extent CD4(+) T cells primed either with the free peptide or T. crassiceps total antigen. The supernatant of the stimulated cells contained high levels of gamma interferon and low levels of interleukin-4. Similar results were obtained with T cells tested for intracellular cytokine production, an indication of the peptide's capacity to induce an inflammatory response. The remarkable protection induced by GK-1 immunization, its physicochemical properties, and its presence in all developmental stages of T. solium point to this synthetic peptide as a strong candidate in the construction of a synthetic vaccine against T. solium pig cysticercosis.
AuthorsA Toledo, C Larralde, G Fragoso, G Gevorkian, K Manoutcharian, M Hernández, G Acero, G Rosas, F López-Casillas, C K Garfias, R Vázquez, I Terrazas, E Sciutto
JournalInfection and immunity (Infect Immun) Vol. 67 Issue 5 Pg. 2522-30 (May 1999) ISSN: 0019-9567 [Print] United States
PMID10225916 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Helminth
  • Antigens, Helminth
  • Epitopes
  • Helminth Proteins
  • Recombinant Proteins
  • Vaccines, Synthetic
  • Interleukin-4
  • Interferon-gamma
Topics
  • Amino Acid Sequence
  • Animals
  • Antibodies, Helminth (blood)
  • Antigens, Helminth (chemistry, genetics)
  • B-Lymphocytes (immunology)
  • Cysticercosis (immunology, prevention & control)
  • Epitopes (chemistry, genetics)
  • Helminth Proteins (chemistry, genetics, immunology)
  • Immunization
  • Interferon-gamma (biosynthesis)
  • Interleukin-4 (biosynthesis)
  • Lymphocyte Activation
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Models, Molecular
  • Molecular Sequence Data
  • Protein Conformation
  • Recombinant Proteins (chemistry, genetics, immunology)
  • Species Specificity
  • T-Lymphocytes (immunology)
  • Taenia (genetics, immunology)
  • Vaccines, Synthetic (genetics, immunology, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: